Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Markert

Showing results (211-220 of 268) with videos related to

Pageof 27
Sort By:
Gene Therapy|February 19, 2002
The use of a genetically engineered herpes simplex virus (R7020) with ionizing radiation for experimental hepatomaS-M Chung, S J Advani, J D Bradley, et al.
Advances in Radiation Oncology|July 26, 2017
A phase 2 study of radiosurgery and temozolomide for patients with 1 to 4 brain metastasesJohn B Fiveash, Waleed O Arafat, George E Naoum, et al.
Plos One|April 18, 2013
Prognostic relevance of cytochrome C oxidase in primary glioblastoma multiformeCorinne E Griguer, Alan B Cantor, Hassan M Fathallah-Shaykh, et al.
Cancer|May 29, 2023
Racial and socioeconomic disparities in glioblastoma outcomes: A single-center, retrospective cohort studyDagoberto Estevez-Ordonez, Moaaz Abdelrashid, Elizabeth Coffee, et al.
Molecular Therapy Oncolytics|October 17, 2017
Newly Characterized Murine Undifferentiated Sarcoma Models Sensitive to Virotherapy with Oncolytic HSV-1 M002Eric K Ring, Rong Li, Blake P Moore, et al.
Archives of Neurology|March 10, 2010
A phase 1 trial of ABT-510 concurrent with standard chemoradiation for patients with newly diagnosed glioblastomaLouis B Nabors, John B Fiveash, James M Markert, et al.
Journal of Neuro-Oncology|June 10, 2010
Preclinical evaluation of ex vivo expanded/activated γδ T cells for immunotherapy of glioblastoma multiformeNichole L Bryant, G Yancey Gillespie, Richard D Lopez, et al.
Journal of Neuro-Oncology|October 21, 2025
Frameless linac-based radiosurgery for benign intracranial tumors treated with HyperArc: analysis of tumor control and toxicityWhitney S Hotsinpiller, Evan M Thomas, Ian Tsekouras, et al.
Scientific Reports|April 17, 2025
Investigation of an oncolytic herpes simplex virus as a potential therapeutic agent for gastroenteropancreatic neuroendocrine neoplasmsColin H Quinn, Janet R Julson, Michael H Erwin, et al.
The Journal of Biological Chemistry|September 28, 2010
Acquisition of temozolomide chemoresistance in gliomas leads to remodeling of mitochondrial electron transport chainClaudia R Oliva, Susan E Nozell, Anne Diers, et al.
Pageof 27

Showing results (211-220 of 268) with videos related to

Sort By:
Pageof 27
Gene Therapy|February 19, 2002
The use of a genetically engineered herpes simplex virus (R7020) with ionizing radiation for experimental hepatomaS-M Chung, S J Advani, J D Bradley, et al.
Advances in Radiation Oncology|July 26, 2017
A phase 2 study of radiosurgery and temozolomide for patients with 1 to 4 brain metastasesJohn B Fiveash, Waleed O Arafat, George E Naoum, et al.
Plos One|April 18, 2013
Prognostic relevance of cytochrome C oxidase in primary glioblastoma multiformeCorinne E Griguer, Alan B Cantor, Hassan M Fathallah-Shaykh, et al.
Cancer|May 29, 2023
Racial and socioeconomic disparities in glioblastoma outcomes: A single-center, retrospective cohort studyDagoberto Estevez-Ordonez, Moaaz Abdelrashid, Elizabeth Coffee, et al.
Molecular Therapy Oncolytics|October 17, 2017
Newly Characterized Murine Undifferentiated Sarcoma Models Sensitive to Virotherapy with Oncolytic HSV-1 M002Eric K Ring, Rong Li, Blake P Moore, et al.
Archives of Neurology|March 10, 2010
A phase 1 trial of ABT-510 concurrent with standard chemoradiation for patients with newly diagnosed glioblastomaLouis B Nabors, John B Fiveash, James M Markert, et al.
Journal of Neuro-Oncology|June 10, 2010
Preclinical evaluation of ex vivo expanded/activated γδ T cells for immunotherapy of glioblastoma multiformeNichole L Bryant, G Yancey Gillespie, Richard D Lopez, et al.
Journal of Neuro-Oncology|October 21, 2025
Frameless linac-based radiosurgery for benign intracranial tumors treated with HyperArc: analysis of tumor control and toxicityWhitney S Hotsinpiller, Evan M Thomas, Ian Tsekouras, et al.
Scientific Reports|April 17, 2025
Investigation of an oncolytic herpes simplex virus as a potential therapeutic agent for gastroenteropancreatic neuroendocrine neoplasmsColin H Quinn, Janet R Julson, Michael H Erwin, et al.
The Journal of Biological Chemistry|September 28, 2010
Acquisition of temozolomide chemoresistance in gliomas leads to remodeling of mitochondrial electron transport chainClaudia R Oliva, Susan E Nozell, Anne Diers, et al.
Pageof 27